| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.5 |